Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Businessweek Archives

Pfizer's Potency Play


In Business This Week: CLOSING BELL

PFIZER'S POTENCY PLAY

Pfizer is getting quite a lift from Viagra. On Mar. 23, Pfizer stock rose 4.5% to close at 96 1/4, after the ABC News program 20/20 did a segment on the company's promising new impotence treatment. Viagra, which may win marketing approval from the Food & Drug Administration any day now, is expected to be a blockbuster, with possible annual sales of $3 billion by 2002. More good news on Mar. 24: Pfizer announced that its deal to co-promote G.D. Searle's upcoming arthritis drug was expanded to include all areas of the globe except Japan. But that wasn't enough to keep its stock aloft, and it closed Mar. 25 at 94 1/2.EDITED BY KELLEY HOLLANDReturn to top

Return to top


LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus